Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

Coronavirus (COVID-19) Resource Center

This guide provides valuable resources for both, Healthcare Professionals (physicians, nurses and practitioners) and Health Consumers about the COVID-19 outbreak and recent research related to this topic.

Below is a list of articles selected by experts, and updated regularly:Experts Pick
 

 

 

 

  • Articles from January to December 2020
  • Articles from year 2021
  • Articles from Jan 2022
  • Articles from Feb 2022
  • Articles from Mar 2022
  • Articles from April 2022
  • Articles from May 2022
  • Articles from June 2022
  • Articles from July 2022
  • Articles from August 2022
  • Articles from September 2022


  • Zuo F, et al. "Mucosal IgA against SARS-CoV-2 Omicron Infection." November 24, 2022 N Engl J Med 2022; 387:e55 https://doi.org/10.1056/NEJMc2213153. 
     
  • Rubin E, et al. "Audio Interview: The FDA and Covid-19 Vaccines."  November 17, 2022 N Engl J Med 2022; 387:e60 https://doi.org/10.1056/NEJMe2214911. 
     
  • Jia M, et al. "Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis." Chin Med J (Engl). 2022 Nov 16. https://doi.org/10.1097/CM9.0000000000002427. 

  • Wilson N, et al. "In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6." NEJM November 16, 2022 https://doi.org/10.1056/NEJMc2211845. 

  • Venkataramani V, et al. "Cognitive Deficits in Long Covid-19." November 10, 2022 N Engl J Med 2022; 387:1813-1815 https://doi.org/10.1056/NEJMcibr2210069. 
     
  • Batram M, et al. "Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany." PLoS Med. 2022 Nov 10;19(11):e1004122. https://doi.org/10.1371/journal.pmed.1004122. eCollection 2022 Nov. 

  • Raifman J, et al. "Universal Masking Policies in Schools and Mitigating the Inequitable Costs of Covid-19." NEJM November 9, 2022 https://doi.org/10.1056/NEJMe2213556. 

  • Rubin E, et al. "Audio Interview: Masking and Covid-19." November 10, 2022 N Engl J Med 2022; 387:e56 https://doi.org/10.1056/NEJMe2214613. 

  • Chemaitelly H, et al. "Covid-19 Vaccine Protection among Children and Adolescents in Qatar." NEJM November 2, 2022 https://doi.org/10.1056/NEJMoa2210058. 
     
  • Agergaard J, et al. "High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: A randomized, phase 2, crossover trial." Lancet Reg Health Eur. 2022 Nov 2:100539. https://doi.org/10.1016/j.lanepe.2022.100539. 
     
  • Canetti M, et al. "Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose." NEJM November 9, 2022 https://doi.org/10.1056/NEJMc2211283. 
     
  • Jacob N, et al. "Effectiveness of the BNT162b2 (Pfizer-BioNTech) Vaccine in Children and Adolescents: A Systematic Review and Meta-Analysis." Vaccines (Basel). 2022 Nov 7;10(11). https://doi.org/10.3390/vaccines10111880. 
     
  • Giamarellos-Bourboulis EJ, et al. "A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019." Nat Metab. 2022 Nov 7. https://doi.org/10.1038/s42255-022-00698-3. 
     
  • Xu X, et al. "Effectiveness of Lianhua Qingwen Capsule in Treatment of Asymptomatic COVID-19 Patients: A Randomized, Controlled Multicenter Trial." J Integr Complement Med. 2022 Nov;28(11):887-894. https://doi.org/10.1089/jicm.2021.0352. Epub 2022 Nov 4. 
  • Trabelsi I, et al. "Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial." Clin Infect Dis. 2022 Nov 4:ciac807. https://doi.org/10.1093/cid/ciac807. 
     
  • Rubin E, et al. "Audio Interview: Caring for Hospitalized Patients with Covid-19." November 3, 2022 N Engl J Med 2022; 387:e51 https://doi.org/10.1056/NEJMe2214245. 
     
  • Brachs M, et al. "Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial." J Transl Med. 2022 Nov 3;20(1):506. https://doi.org/10.1186/s12967-022-03660-9. 
     
  • Rosa Gastaldo C, et al. "Individuals with hearing impairment/deafness during the COVID-19 pandemic: A rapid review on communication challenges and strategies." J Clin Nurs. 2022 Nov 1. https://doi.org/10.1111/jocn.16572. (Systematic review) 
     
  • Johnstone H, et al. "Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial." EBioMedicine. 2022 Nov 1;86:104322. https://doi.org/10.1016/j.ebiom.2022.104322.